CryoLife’s E-nside multibranch stent graft system, a device used to treat aneurysms in patients with thoracoabdominal disease, has received the CE Mark.

The product’s inner branches are pre-cannulated to reduce the overall procedure time and the patients’ exposure to radiation.

The device will eliminate “the waiting period experienced by approximately 70 percent of patients who would normally require a custom-made stent graft,” said CryoLife President and CEO Pat Mackin.